Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 1998, p. 725-726, Vol. 42, No. 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Morphological Effects of Miconazole on Helicobacter pylori
 |
LETTER |
Helicobacter pylori is the causative agent of chronic
superficial gastritis and contributes to the pathogenesis of peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric
adenocarcinoma (4). The antimycotic miconazole has been
shown to be bacteriostatically active against H. pylori
(6, 8); however, details of the action of the substance are
not known. The aim of the present study was therefore to investigate the morphological changes induced by miconazole.
H. pylori IMMi 95-451 was cultured microaerophilically in
3.0 ml of brain heart infusion broth (CM 225; Oxoid, Basingstoke, United Kingdom) supplemented with 10% newborn calf serum (no. 14-416 A; Serva, Heidelberg, Germany) and 0.25% yeast extract (no. 30-000-49;
Flow, Meckenheim, Germany) (BNY broth) in tissue culture flasks with a
volume of 50 ml (no. 690160; Greiner, Frickenhausen, Germany). The BNY
broth cultures reached a cell density of at least 3 × 108 cells per ml. To obtain cultures with >90% intact and
viable cells, two transfers of 1.5 ml of H. pylori culture
in 1.5 ml of fresh BNY broth were made after 24 and 48 h. To the
48-h cultures, miconazole (Biotrend, Cologne, Germany) was added to
reach a final concentration of 16 µg/ml. After another 24 h of
incubation, 3.0-ml suspensions of treated cultures and controls without
antibiotic were fixed for 1 h in 2% glutaraldehyde in cacodylate
buffer (100 mmol) and then in 1% osmium tetroxide and 2% uranyl
acetate. The organisms were deposited by centrifugations for 2 min at
8,000 × g. The final cell pellet was dehydrated in
acetone and embedded in glycidether (Epon 812). Sections were mounted
on copper grids and stained for 20 s with 4% lead citrate.
Microphotographs were obtained with a Zeiss EM 10 transmission electron
microscope at an accelerating voltage of 60 kV.
Most of the untreated control cells appeared as slightly curved or
straight bacilli. The cells with intact membranes and a dense cytoplasm
had a diameter of about 0.5 µm (Fig.
1A). Cultures exposed to miconazole for
24 h revealed few bacteria with intact shape and structure. Most
cells were swollen, with diameters up to 1.5 µm, or heavily destroyed
(Fig. 1B). However, intact flagellar and submembranous dense structures
were still found in the treated cells. Round cell forms with intact
cytoplasms and membranes were rarely found in treated cultures.

View larger version (143K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of miconazole on the structure of H. pylori cells (strain IMMi 95-451). (A) Typically curved bacteria
with polar flagellae in untreated controls are seen. (B) Swollen and
destroyed bacteria predominate after treatment for 24 h with 16 µg of miconazole per ml. Bar represents 1 µm.
|
|
The inhibitory activity of miconazole (MIC range of 2 to 32 µg/ml)
and of other nitroimidazole antimycotics against H. pylori was recently noted (6-8). Until now, bactericidal activity
of miconazole against H. pylori has not been documented. The
electron microscopic investigations prove the destructive action of
miconazole on H. pylori. The replacement of the normal
bacilliform morphology by cell wall blebbing, lytic cells, and
vesiculation was similar to the changes seen with beta-lactam
antibiotics, shown in an earlier study (2). However, in
contrast to the observations of Berry et al. (3) on the
effects of amoxicillin against H. pylori, round or coccoid
cell forms were not induced by the miconazole treatment.
Imidazole antimycotics impair ergosterol synthesis of the cytoplasmic
membrane in yeasts and molds. It can be speculated that these
substances may interfere with cholesterol metabolism in H. pylori. This is unique and characteristic of this organism (1, 5).
 |
REFERENCES |
| 1.
|
Ansorg, R.,
K.-D. Müller,
G. von Recklinghausen, and H. P. Nalik.
1992.
Cholesterol binding of Helicobacter pylori.
Zentralbl. Bakteriol.
276:323-329[Medline].
|
| 2.
|
Armstrong, J. A.,
S. H. Wee,
C. S. Goodwin, and D. H. Wilson.
1987.
Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro an ultrastructural study.
J. Med. Microbiol.
24:343-350[Abstract/Free Full Text].
|
| 3.
|
Berry, V.,
K. Jennings, and G. Woodnutt.
1995.
Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.
Antimicrob. Agents Chemother.
39:1859-1861[Abstract].
|
| 4.
|
Blaser, M. J.
1995.
Helicobacter pylori and related organisms, p. 1956-1964.
In
G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York.
|
| 5.
|
Hirai, Y.,
M. Haque,
T. Yoshida,
K. Yokota,
T. Yasuda, and K. Oguma.
1995.
Unique cholesteryl glycosides in Helicobacter pylori: composition and structural analysis.
J. Bacteriol.
177:5327-5333[Abstract/Free Full Text].
|
| 6.
|
Rautelin, H.,
O.-V. Renkonen, and T. U. Kosunen.
1992.
In vitro activity of antifungal azoles against Helicobacter pylori.
Eur. J. Clin. Microbiol. Infect. Dis.
11:273-274[Medline]. (Letter.)
|
| 7.
|
von Recklinghausen, G.,
C. di Maio, and R. Ansorg.
1992.
Activity of the antimycotic ketoconazole against Helicobacter pylori.
J. Antimicrob. Chemother.
30:238-240[Free Full Text]. (Letter.)
|
| 8.
|
von Recklinghausen, G.,
C. di Maio, and R. Ansorg.
1993.
Activity of antibiotics and azole antimycotics against Helicobacter pylori.
Zentralbl. Bakteriol.
280:279-285[Medline].
|
| | | | |
G. von Recklinghausen
E. N. Schmid
A. Vollmer
R. Ansorg
Institute of Medical Microbiology University of Essen Hufelandstr. 55 D-45122 Essen Germany
|
Antimicrobial Agents and Chemotherapy, March 1998, p. 725-726, Vol. 42, No. 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.